Aurora Cannabis shares are trading lower after-hours: here’s why

The U.S. listed shares of Aurora Cannabis Inc (NYSE: ACB) are down more than 2.0% in after-hours trading as the company said its revenue tanked 45% in the fiscal fourth quarter on a year-over-year basis.

Financial performance

Aurora remained in $106 million of net loss in its recent quarter versus the year-ago figure of $1.8 billion in net loss. The Canadian firm did not disclose its per-share loss for the quarter.

The Edmonton-based firm generated $43 million in revenue – a decline from last year’s $54 million. According to FactSet, experts had forecast the company to post $44.67 million in revenue.

Other notable figures

The licensed producer of cannabis attributed the decline in Q4 revenue to weak consumer demand due to the Coronavirus restrictions. Revenue from medical cannabis, however, jumped 9% on an annualised basis in the fourth quarter.

Aurora valued its cash stature at $440.9 million at the end of its Q4. Cannabis flower prices were 42% in the recent quarter, as per the earnings press release.

CEO Martin’s comments

Commenting on the financial update on Monday, CEO Miguel Martin said:

With annual cost savings of approximately $60 to $80 million, we have a clear pathway to achieve Adjusted EBITDA profitability. Importantly, our considerable cash balance of $440.9 million, substantial improvement in working capital, and strong balance sheet support our organic growth and can be utilised for opportunistic M&A, particularly in the U.S.

The stock is still down more than 50% from its year-to-date high of $18.92 in February.